Carlene MacMillan, M.D., a Harvard-trained adult and child psychiatrist, is the VP of Clinical Innovation at Osmind. Osmind is a platform that enables clinicians to deliver breakthrough mental health treatments. She is the Co-Chair of the Clinical TMS Society Insurance Committee and the Co-Chair of the American Academy of Child and Adolescent Psychiatry Consumer Issues Committee. Dr. MacMillan is also a member of the Ketamine Taskforce for Access to Safe Care and Insurance Coverage.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.